Long-term natalizumab treatment is associated with a reduction in lesional white matter levels of myo-inostiol, a biomarker of gliotic activity

MM Schoonheim, LE Jonkman, AJC Eijlers, KA Meijer, J Killestein, JJG Geurts

Research output: Contribution to conferencePosterAcademic

Original languageEnglish
Publication statusPublished - 1 Jul 2019
Event5th Congress of the European Academy of Neurology - Oslo, Norway
Duration: 29 Jun 20192 Jul 2019

Conference

Conference5th Congress of the European Academy of Neurology
Abbreviated titleEAN
CountryNorway
CityOslo
Period29/06/201902/07/2019

Cite this